IL-17A-binding polypeptides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10934335
APP PUB NO 20170362290A1
SERIAL NO

15538890

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to a class of engineered polypeptides having a binding affinity for interleukin-17A (IL-17A), and provides an IL-17A binding polypeptide comprising the sequence EX2DX4AX6X7EIX10X11 LPNL X16X17X18QX20X21AFIX25 X26LX28X29. Also disclosed is the use of such an interleukin-17A binding polypeptide as a diagnostic, prognostic and/or therapeutic agent.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AFFIBODY AB171 65 SOLNA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Feldwisch, Joachim Tyresö, SE 18 47
Frejd, Fredrik Stockholm, SE 15 37
Gudmundsdotter, Lindvi Stockholm, SE 6 1
Klint, Susanne Stockholm, SE 4 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 2, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 2, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00